Epidemiology of Breast Cancer in Women based on Diagnosis Data from Oncologists and Breast Surgeons in Algeria

Trial Identifier: D133FR00109
Sponsor:AstraZeneca
NCTID:NCT02733601
Start Date:May 2016
Primary Completion Date: March 2022
Study Completion Date: March 2022
Condition: Breast Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

CountryLocation
Algeria, Middle of Algeria Middle of Algeria, Algeria, 16 000
Algeria, East of Algeria East of Algeria, Algeria, 25 000
Algeria, Ouest of Algeria/ Oran Region Ouest of Algeria/ Oran Region, Algeria, 31 000